Oxygen Delivery Devices Market Size, Share, Growth, and Industry Analysis, By Type (Low Flow Delivery Devices,High Flow Delivery Devices), By Application (Chronic Obstructive Pulmonary Disease,Asthma,Obstructive Sleep Apnea,Respiratory Distress Syndrome,Cystic Fibrosis,Pneumonia), Regional Insights and Forecast to 2035

Unique Information about the Oxygen Delivery Devices Market

Global Oxygen Delivery Devices market size is estimated at USD 745.61 million in 2026, set to expand to USD 922.11 million by 2035, growing at a CAGR of 2.4%.

The Oxygen Delivery Devices Market represents a critical segment of the global respiratory care industry, supporting more than 300 million patients suffering from chronic respiratory diseases worldwide. Medical oxygen therapy is used in approximately 15% of hospitalized patients globally, while over 40 million individuals require long-term oxygen therapy at home. Oxygen delivery devices include nasal cannulas, oxygen masks, high-flow systems, and ventilator-compatible delivery components used in hospitals, ambulatory surgical centers, and home care settings. Globally, more than 120 million oxygen cylinders and 20 million oxygen concentrators are actively used in healthcare infrastructure. In hospital intensive care units, oxygen therapy usage exceeds 60% of respiratory treatment protocols, highlighting strong demand for advanced oxygen delivery devices. The Oxygen Delivery Devices Market Analysis indicates that respiratory disorders account for nearly 8% of global deaths, increasing the adoption of precise oxygen administration technologies. Additionally, healthcare systems across 80+ countries have integrated standardized oxygen therapy protocols to improve patient survival rates.

The United States Oxygen Delivery Devices Market demonstrates significant clinical utilization due to high respiratory disease prevalence and advanced hospital infrastructure. Approximately 25 million Americans suffer from asthma, while more than 16 million adults are diagnosed with chronic obstructive pulmonary disease (COPD). Hospitals in the United States administer oxygen therapy to nearly 1.2 million patients annually in emergency departments and over 900,000 intensive care admissions. Home oxygen therapy is used by roughly 1.5 million patients, supported by more than 2.8 million oxygen concentrators operating across households. The Oxygen Delivery Devices Industry Analysis also shows that over 6,000 hospitals and 11,000 ambulatory care facilities in the country maintain oxygen delivery systems as essential respiratory equipment. Additionally, approximately 85% of critical care ventilators in U.S. hospitals incorporate integrated oxygen delivery modules. With respiratory diseases responsible for nearly 1 in every 12 deaths in the country, the Oxygen Delivery Devices Market Outlook remains closely linked to respiratory treatment demand and emergency healthcare preparedness.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: About 65% demand increase comes from respiratory disease prevalence, 58% hospital protocol usage, and 72% adoption through chronic respiratory disease management programs.
• Major Market Restraint: Approximately 41% facilities report maintenance issues, 37% replacement delays, and 33% procurement barriers due to regulatory compliance requirements across healthcare systems.
• Emerging Trends: Nearly 54% hospitals adopt high-flow systems, 47% growth in portable concentrators, and 39% providers integrate smart monitoring features into oxygen delivery devices.
• Regional Leadership: North America holds 36% device usage, Europe 29% deployment, Asia-Pacific 25% installations, while remaining regions collectively contribute around 10% adoption.
• Competitive Landscape: Leading manufacturers control about 48% market share, mid-size companies 32%, while specialized oxygen therapy device manufacturers hold nearly 20% share.
• Market Segmentation: Low-flow oxygen delivery devices account for 62% clinical usage, while high-flow systems represent 38% utilization in critical care respiratory treatment environments.
• Recent Development: Around 46% new launches focus on portable systems, 42% innovations target high-flow therapy, and 38% upgrades integrate digital monitoring technology.

Oxygen Delivery Devices Market Latest Trends

The Oxygen Delivery Devices Market Trends demonstrate strong expansion due to increasing respiratory disease cases and healthcare infrastructure modernization. Globally, respiratory disorders affect more than 545 million people, with COPD accounting for nearly 3.2 million deaths annually. Oxygen therapy devices are used in approximately 75% of intensive care respiratory treatments, making them essential hospital equipment. The adoption of high-flow nasal cannula systems has increased by more than 40% in critical care units over the past decade. Portable oxygen concentrators are becoming a major trend in the Oxygen Delivery Devices Industry Report, with nearly 3.5 million portable units currently used worldwide. Hospitals and home care providers increasingly prefer lightweight systems weighing less than 2.5 kilograms, enabling greater mobility for chronic respiratory patients.

Additionally, nearly 52% of oxygen therapy patients in developed healthcare systems now receive treatment outside hospital settings. Digital integration is another key trend shaping the Oxygen Delivery Devices Market Insights. Around 48% of new oxygen therapy systems include digital flow control and remote monitoring capabilities. Smart sensors measuring oxygen saturation are now integrated into nearly 33% of newly introduced oxygen delivery systems. Healthcare infrastructure expansion also supports the Oxygen Delivery Devices Market Forecast, as more than 90 countries are increasing oxygen supply capacity in hospitals. Globally, over 70,000 new ICU beds have been added in recent years, each requiring oxygen therapy systems capable of delivering 15–60 liters per minute for advanced respiratory support.

Oxygen Delivery Devices Market Dynamics

DRIVER

"Rising demand for respiratory disease treatment"

The increasing global burden of respiratory diseases is a primary driver in the Oxygen Delivery Devices Market Growth. Chronic obstructive pulmonary disease affects approximately 392 million individuals worldwide, while asthma impacts more than 260 million people. Hospitals administer oxygen therapy to nearly 70% of acute respiratory patients, and emergency departments use oxygen delivery devices in approximately 80% of respiratory distress cases. Aging populations further contribute to demand, as individuals aged 65 years and older represent nearly 16% of the global population, with respiratory disorders affecting over 25% of this demographic. In addition, home oxygen therapy usage has increased by nearly 45% over the past decade, supported by portable oxygen delivery technologies. These trends significantly strengthen the Oxygen Delivery Devices Market Opportunities, especially in long-term care and home healthcare segments.

RESTRAINT

"Infrastructure limitations in healthcare facilities"

Despite growing demand, infrastructure limitations remain a challenge in the Oxygen Delivery Devices Industry Analysis. Approximately 35% of healthcare facilities in low-income regions lack reliable oxygen supply systems. Hospitals in several developing regions report oxygen equipment shortages affecting nearly 28% of respiratory treatment cases. Maintenance and servicing of oxygen delivery equipment also pose challenges, as nearly 32% of hospitals experience equipment downtime due to inadequate technical support. In addition, regulatory approval procedures for medical devices require compliance with more than 20 international standards, creating delays in product availability across multiple healthcare systems. These factors restrict consistent adoption of advanced oxygen delivery devices.

OPPORTUNITY

"Expansion of home healthcare services"

The rapid expansion of home healthcare services presents major opportunities for the Oxygen Delivery Devices Market Outlook. Globally, more than 65 million patients receive healthcare services at home each year, and approximately 12% of them require oxygen therapy support. Portable oxygen concentrators weighing under 3 kilograms are now used by nearly 1.8 million home-based respiratory patients. Telemedicine integration has also improved monitoring of oxygen therapy, with around 40% of remote patient monitoring programs including oxygen saturation tracking. In addition, healthcare providers are expanding home respiratory care programs in over 50 countries, increasing demand for compact oxygen delivery devices designed for non-hospital environments.

CHALLENGE

"Rising costs and technical complexity"

Technological complexity presents a significant challenge within the Oxygen Delivery Devices Market Research Report. Advanced high-flow oxygen therapy systems require oxygen flow rates of up to 60 liters per minute, necessitating specialized infrastructure and trained clinical personnel. Approximately 44% of healthcare providers report training requirements for operating advanced oxygen delivery devices. Equipment servicing and calibration must be conducted every 6 to 12 months, increasing operational complexity for hospitals. Additionally, oxygen supply logistics require specialized storage systems capable of handling up to 200 bar pressure in medical cylinders. These technical factors create operational barriers for healthcare facilities with limited technical resources.

Segmentation Analysis

The Oxygen Delivery Devices Market Size is segmented by type and application, reflecting varied clinical needs in respiratory therapy. Low-flow oxygen delivery systems dominate hospital and home healthcare usage due to their ability to deliver oxygen at rates between 1 and 15 liters per minute. High-flow oxygen systems are increasingly used in critical care units with oxygen flow rates reaching 60 liters per minute. By application, chronic obstructive pulmonary disease represents the largest patient group requiring oxygen therapy, followed by asthma and obstructive sleep apnea. Hospitals account for nearly 70% of oxygen delivery device utilization, while home healthcare settings represent approximately 25% usage.

Download FREE Sample to learn more about this report.

By Type

Low Flow Delivery Devices: Low-flow oxygen delivery devices account for approximately 62% of total device utilization in the Oxygen Delivery Devices Market Analysis. These devices typically deliver oxygen at flow rates between 1 and 15 liters per minute, making them suitable for stable respiratory patients. Nasal cannulas are among the most widely used low-flow devices, utilized in nearly 65% of oxygen therapy treatments globally. Oxygen masks and simple face masks are also used in approximately 22% of respiratory care procedures. Hospitals prefer low-flow devices because they require minimal infrastructure and can operate with standard oxygen cylinders containing up to 7,000 liters of oxygen gas. In home healthcare environments, more than 70% of oxygen therapy patients use nasal cannulas connected to portable oxygen concentrators delivering oxygen concentrations between 85% and 95%.

High Flow Delivery Devices: High-flow oxygen delivery devices represent nearly 38% of total device installations in the Oxygen Delivery Devices Industry Analysis. These systems deliver oxygen flow rates ranging from 30 to 60 liters per minute, supporting patients with severe respiratory distress. High-flow nasal cannula systems are increasingly used in intensive care units and neonatal care units. Approximately 55% of ICU respiratory therapy protocols include high-flow oxygen therapy. These devices provide oxygen concentrations of up to 100%, enabling improved oxygen saturation levels for critically ill patients. Hospitals equipped with advanced respiratory care units maintain high-flow oxygen therapy systems capable of supporting more than 20 patients simultaneously through centralized oxygen supply infrastructure.

By Application

Chronic Obstructive Pulmonary Disease (COPD): Chronic Obstructive Pulmonary Disease represents the largest application segment in the Oxygen Delivery Devices Market Insights, accounting for nearly 34% of global oxygen therapy usage. Globally, more than 392 million individuals live with COPD, and approximately 15% of these patients require long-term oxygen therapy to maintain stable respiratory function. Hospitals manage nearly 3 million COPD exacerbation cases annually, where oxygen delivery devices are used to maintain blood oxygen saturation above 90%. In clinical settings, oxygen flow rates between 2 and 6 liters per minute are commonly used for COPD management. In home healthcare environments, more than 1 million COPD patients rely on portable oxygen concentrators delivering oxygen flow rates of 2 to 5 liters per minute.

Asthma: Asthma is a major respiratory condition influencing the Oxygen Delivery Devices Market Analysis, affecting more than 260 million people globally. Approximately 10% of severe asthma patients require oxygen therapy during acute respiratory attacks. Emergency departments handle more than 20 million asthma-related visits annually, and oxygen delivery devices are used in around 65% of severe cases requiring respiratory stabilization. Oxygen masks and nebulizer-integrated oxygen therapy systems are frequently used in hospitals to support airflow and maintain oxygen saturation above 92%. Oxygen therapy for asthma typically delivers oxygen concentrations ranging from 24% to 60%, while oxygen flow rates usually range between 4 and 10 liters per minute during emergency treatment procedures.

Obstructive Sleep Apnea: Obstructive sleep apnea significantly contributes to demand within the Oxygen Delivery Devices Market Research Report, affecting approximately 936 million individuals worldwide. Nearly 80 million patients receive respiratory therapy interventions to manage sleep apnea complications. Oxygen delivery devices are used alongside continuous positive airway pressure systems in about 18% of treatment cases where oxygen saturation drops during sleep. Hospitals conducting sleep diagnostic studies utilize oxygen delivery equipment in nearly 40% of respiratory monitoring procedures. These systems help maintain oxygen saturation levels above 90% during overnight monitoring.

Respiratory Distress Syndrome: Respiratory distress syndrome is a critical neonatal condition influencing the Oxygen Delivery Devices Market Size, affecting approximately 15 million premature infants worldwide each year. Neonatal intensive care units depend heavily on oxygen delivery devices to provide controlled oxygen therapy for newborns with underdeveloped lungs. Oxygen delivery systems in neonatal care provide adjustable oxygen concentrations ranging from 21% to 100% to ensure safe respiratory support. High-flow oxygen therapy systems are used in nearly 60% of neonatal respiratory treatment procedures, particularly for infants experiencing severe breathing difficulties.

Cystic Fibrosis: Cystic fibrosis represents a specialized application area in the Oxygen Delivery Devices Industry Analysis, affecting approximately 105,000 patients worldwide. This genetic respiratory disease leads to progressive lung damage, requiring oxygen therapy in nearly 35% of advanced disease cases. Hospitals treating cystic fibrosis complications use oxygen delivery devices to maintain oxygen saturation levels above 92%, particularly during respiratory infections or lung function deterioration. In hospital environments, oxygen flow rates typically range between 3 and 8 liters per minute for acute respiratory support.

Pneumonia: Pneumonia is one of the most common respiratory infections driving demand in the Oxygen Delivery Devices Market Outlook, affecting nearly 450 million individuals each year worldwide. The disease results in approximately 2.5 million deaths annually, particularly among elderly populations and young children. Oxygen therapy is required in nearly 70% of severe pneumonia hospitalizations, as patients frequently experience reduced oxygen saturation levels below 90%. Hospitals commonly use oxygen masks, nasal cannulas, and high-flow nasal cannula systems to stabilize respiratory function. Oxygen flow rates during pneumonia treatment typically range between 5 and 15 liters per minute, depending on disease severity and the patient’s respiratory condition.\

Regional Outlook

The Oxygen Delivery Devices Market Outlook shows strong adoption across multiple healthcare systems. North America leads the market due to advanced hospital infrastructure and high respiratory disease prevalence. Europe follows with widespread healthcare coverage and established respiratory care programs. Asia-Pacific is experiencing rapid healthcare expansion, increasing oxygen therapy installations in hospitals. The Middle East & Africa region is improving oxygen supply infrastructure in response to respiratory disease management initiatives.

Download FREE Sample to learn more about this report.

North America

North America holds approximately 36% of the global Oxygen Delivery Devices Market Share, supported by highly developed healthcare infrastructure and widespread adoption of advanced respiratory care technologies. The region operates more than 6,100 hospitals, many of which are equipped with centralized oxygen distribution networks that can supply oxygen simultaneously to over 100 patient beds. In addition, North America has nearly 95,000 intensive care unit (ICU) beds, each requiring integrated oxygen delivery systems capable of providing oxygen flow rates between 1 liter per minute and 60 liters per minute depending on patient severity.

The United States represents the largest contributor within the region, with around 1.5 million patients receiving long-term oxygen therapy every year. Chronic respiratory diseases remain highly prevalent, with more than 25 million asthma patients and approximately 16 million individuals diagnosed with chronic obstructive pulmonary disease. Canada also contributes significantly to the Oxygen Delivery Devices Market Analysis, as more than 2.4 million people live with respiratory diseases that require periodic oxygen therapy support.

Hospitals across North America increasingly rely on advanced oxygen therapy equipment. High-flow nasal cannula systems are used in more than 50% of critical care respiratory treatment protocols, particularly for acute respiratory failure. Home healthcare adoption is also expanding rapidly, with more than 800,000 portable oxygen concentrators currently used by patients receiving oxygen therapy outside hospital environments.

Europe

Europe accounts for nearly 29% of the global Oxygen Delivery Devices Market Size, driven by comprehensive public healthcare systems and strong respiratory disease management programs. The region includes more than 15,000 hospitals, many of which are equipped with centralized oxygen pipeline systems capable of distributing medical oxygen throughout operating rooms, emergency departments, and intensive care units. These hospitals utilize oxygen delivery devices extensively to manage respiratory conditions affecting approximately 210 million individuals across Europe.

Chronic obstructive pulmonary disease represents a major contributor to the Oxygen Delivery Devices Market Insights, accounting for nearly 10% of respiratory diagnoses among adults in the region. Hospitals in countries such as Germany, France, Italy, and the United Kingdom administer oxygen therapy to around 2 million patients each year during emergency care and inpatient respiratory treatment. Oxygen masks, nasal cannulas, and high-flow oxygen therapy systems are among the most commonly used respiratory devices in European hospitals.

Home oxygen therapy programs are also widely implemented across Europe. More than 1 million patients receive oxygen therapy in home healthcare settings, supported by portable oxygen concentrators and oxygen cylinders. Portable concentrators are used in approximately 45% of home treatment cases, allowing patients to maintain oxygen saturation levels above 90% while performing daily activities. Intensive care units throughout Europe increasingly deploy high-flow oxygen therapy systems capable of delivering oxygen flow rates exceeding 50 liters per minute for critically ill patients.

Asia-Pacific

Asia-Pacific represents approximately 25% of the global Oxygen Delivery Devices Market Growth, supported by a large patient population and rapidly expanding healthcare infrastructure. The region contains more than 25,000 hospitals and over 150,000 intensive care unit beds equipped with oxygen therapy systems. Increasing respiratory disease prevalence is a key factor driving demand for oxygen delivery equipment, as nearly 400 million people across Asia-Pacific suffer from respiratory conditions such as asthma, chronic obstructive pulmonary disease, and pneumonia.

Countries including China, India, Japan, and South Korea are making significant investments in respiratory care infrastructure. Hospitals across the region have installed more than 500,000 oxygen concentrators to support emergency care, intensive care units, and long-term respiratory treatment programs. Governments are also strengthening oxygen supply capacity by establishing oxygen generation plants capable of producing more than 2 million liters of medical oxygen per day to support healthcare facilities.

Urban tertiary care hospitals are increasingly adopting advanced respiratory equipment. Approximately 35% of tertiary hospitals now use high-flow oxygen therapy systems capable of delivering oxygen flow rates between 30 and 60 liters per minute. Home healthcare adoption is also expanding as aging populations increase demand for long-term respiratory therapy. Portable oxygen concentrators and oxygen cylinders are being used by a growing number of patients requiring continuous oxygen therapy to maintain oxygen saturation levels above 90%.

Middle East & Africa

The Middle East & Africa region represents approximately 10% of the global Oxygen Delivery Devices Market Opportunities, driven by ongoing healthcare infrastructure development and rising awareness of respiratory disease treatment. The region includes more than 9,000 hospitals, many of which are undergoing modernization programs to improve respiratory care capabilities and install advanced oxygen delivery systems.

Respiratory diseases affect approximately 100 million individuals across the Middle East and Africa, contributing to increasing demand for oxygen therapy equipment in hospitals and emergency departments. Oxygen delivery devices are used in nearly 60% of hospital respiratory treatment cases, particularly for pneumonia, asthma attacks, and acute respiratory distress conditions. Hospitals rely on oxygen masks, nasal cannulas, and high-flow oxygen therapy systems to maintain oxygen saturation levels above 90% in patients with respiratory complications.

Several countries in the region are expanding oxygen supply infrastructure. Saudi Arabia and the United Arab Emirates have installed oxygen generation plants capable of producing more than 20,000 cubic meters of medical oxygen per day to support hospital networks. In Africa, healthcare infrastructure expansion programs have provided oxygen delivery equipment to more than 3,000 healthcare facilities, improving access to respiratory care. Additionally, international healthcare initiatives are increasing oxygen therapy capacity in rural hospitals, enabling thousands of patients to receive essential oxygen treatment for severe respiratory illnesses.

Top Companies by Market Share

• ResMed – holds approximately 17% global market share in respiratory therapy devices, with more than 8 million respiratory devices installed worldwide.
• GE Healthcare – accounts for nearly 14% market share in hospital respiratory equipment, supplying oxygen delivery systems to more than 140 countries.

Investment Analysis and Opportunities

The Oxygen Delivery Devices Market Opportunities are expanding significantly as global healthcare systems increase investments in respiratory care infrastructure and oxygen supply systems. Large hospital networks are installing advanced oxygen production plants capable of generating more than 500,000 liters of medical oxygen per day, ensuring continuous oxygen availability for emergency and critical care units. Governments across more than 120 countries have implemented national programs focused on strengthening oxygen supply chains, expanding medical oxygen storage facilities, and improving hospital oxygen pipeline systems. These initiatives are increasing the adoption of oxygen delivery equipment across public healthcare institutions.

Investments are also rising in the portable oxygen concentrator segment, with global manufacturing output exceeding 3 million units annually to support home healthcare patients suffering from chronic respiratory disorders. Hospitals are modernizing respiratory care departments by installing high-flow oxygen therapy systems capable of delivering oxygen flow rates of up to 60 liters per minute, which are commonly used in intensive care units for patients with severe respiratory distress. Healthcare infrastructure expansion has also resulted in the addition of more than 70,000 new ICU beds globally, and each intensive care bed requires integrated oxygen therapy equipment.

Private healthcare providers are further investing in telemedicine-enabled respiratory monitoring systems. Nearly 40% of newly deployed respiratory monitoring platforms now include oxygen saturation tracking integrated with oxygen delivery devices. Medical device manufacturers are investing in miniaturization technologies to develop oxygen concentrators weighing less than 2 kilograms, while maintaining oxygen purity levels between 90% and 96%.

New Product Development

Innovation in the Oxygen Delivery Devices Market Research Report is largely focused on improving oxygen delivery accuracy, patient comfort, and device portability. High-flow nasal cannula technology has advanced significantly, with new systems capable of delivering oxygen flow rates of up to 60 liters per minute. These devices also maintain humidity levels between 90% and 100%, which helps reduce airway dryness and improves respiratory therapy outcomes in intensive care environments. Advanced oxygen therapy systems now incorporate automated oxygen flow adjustment features that respond to real-time oxygen saturation readings, ensuring patients maintain oxygen saturation levels above 90%.

Portable oxygen concentrators are among the most rapidly evolving product segments in the Oxygen Delivery Devices Industry Analysis. Newly developed models weigh between 1.8 kilograms and 2.3 kilograms and can operate for 8 to 10 hours using rechargeable lithium battery systems. These portable devices deliver oxygen concentrations reaching 95% purity, allowing patients with chronic respiratory diseases to maintain oxygen therapy while traveling or performing daily activities.

Another major innovation trend involves digital integration in oxygen delivery equipment. Approximately 35% of newly introduced oxygen therapy devices feature Bluetooth-enabled connectivity, allowing physicians and respiratory therapists to monitor oxygen saturation levels and device performance remotely. Manufacturers are also designing lightweight nasal cannulas and oxygen masks with optimized airflow channels, improving oxygen delivery efficiency by nearly 20% compared to conventional respiratory devices.

Five Recent Developments (2023–2025)

• In 2024, a leading respiratory device manufacturer introduced a high-flow oxygen therapy system capable of delivering 60 liters per minute with humidity levels exceeding 95% for intensive care treatment.
• In 2023, a medical technology company launched a portable oxygen concentrator weighing 2.1 kilograms, providing oxygen purity levels between 90% and 96% for home oxygen therapy patients.
• In 2025, a hospital equipment manufacturer installed centralized oxygen distribution systems in more than 500 healthcare facilities, supporting oxygen delivery to over 50 patient beds simultaneously.
• In 2024, a respiratory care company released a digital oxygen delivery device with integrated oxygen saturation monitoring capable of transmitting patient data every 30 seconds to healthcare providers.
• In 2023, a global medical equipment provider expanded production capacity to manufacture more than 250,000 oxygen delivery devices annually to support rising respiratory treatment demand.

Report Coverage of Oxygen Delivery Devices Market

The Oxygen Delivery Devices Market Report provides an extensive evaluation of respiratory therapy equipment used in multiple healthcare environments such as hospitals, ambulatory surgical centers, and home healthcare settings. The report assesses more than 20 different categories of oxygen delivery devices, including nasal cannulas, oxygen masks, oxygen concentrators, high-flow oxygen therapy systems, and ventilator-integrated oxygen delivery modules. These devices are widely used in clinical settings to maintain oxygen saturation levels above 90% in patients with respiratory disorders. The report analyzes device usage across 50+ healthcare systems globally, with operational data collected from over 200,000 hospitals and medical facilities that routinely administer oxygen therapy as part of respiratory care protocols.

The Oxygen Delivery Devices Market Research Report also focuses on the growing demand for oxygen therapy among patients suffering from respiratory conditions. Globally, more than 545 million people are affected by respiratory diseases such as chronic obstructive pulmonary disease, asthma, pneumonia, and sleep apnea. Oxygen therapy devices deliver controlled oxygen flow ranging from 1 liter per minute for mild respiratory support to nearly 60 liters per minute for severe respiratory distress cases. These variations allow clinicians to tailor oxygen therapy according to patient condition, treatment duration, and clinical severity.

In addition, the Oxygen Delivery Devices Industry Analysis includes healthcare infrastructure insights, covering more than 500,000 oxygen concentrators currently operating in medical facilities worldwide and approximately 120 million medical oxygen cylinders used in hospitals and emergency care units. The report also highlights the installation of numerous centralized oxygen generation plants that supply oxygen to large healthcare facilities. Hospital respiratory departments utilize oxygen delivery devices in more than 70% of respiratory treatment cases, while portable oxygen delivery systems support over 3 million patients receiving long-term oxygen therapy at home.